Cargando…

Standardised 3D-CT lung volumes for patients with idiopathic pulmonary fibrosis

BACKGROUND: The assessment of lung physiology via pulmonary function tests (PFTs) is essential for patients with idiopathic pulmonary fibrosis (IPF). However, PFTs require active participation, which can be challenging for patients with severe respiratory failure, such as during moments of acute exa...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanaka, Yuko, Suzuki, Yuzo, Hasegawa, Hirotsugu, Yokomura, Koshi, Fukada, Atsuki, Inoue, Yusuke, Hozumi, Hironao, Karayama, Masato, Furuhashi, Kazuki, Enomoto, Noriyuki, Fujisawa, Tomoyuki, Nakamura, Yutaro, Inui, Naoki, Suda, Takafumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9161591/
https://www.ncbi.nlm.nih.gov/pubmed/35650599
http://dx.doi.org/10.1186/s12931-022-02062-1
_version_ 1784719517855776768
author Tanaka, Yuko
Suzuki, Yuzo
Hasegawa, Hirotsugu
Yokomura, Koshi
Fukada, Atsuki
Inoue, Yusuke
Hozumi, Hironao
Karayama, Masato
Furuhashi, Kazuki
Enomoto, Noriyuki
Fujisawa, Tomoyuki
Nakamura, Yutaro
Inui, Naoki
Suda, Takafumi
author_facet Tanaka, Yuko
Suzuki, Yuzo
Hasegawa, Hirotsugu
Yokomura, Koshi
Fukada, Atsuki
Inoue, Yusuke
Hozumi, Hironao
Karayama, Masato
Furuhashi, Kazuki
Enomoto, Noriyuki
Fujisawa, Tomoyuki
Nakamura, Yutaro
Inui, Naoki
Suda, Takafumi
author_sort Tanaka, Yuko
collection PubMed
description BACKGROUND: The assessment of lung physiology via pulmonary function tests (PFTs) is essential for patients with idiopathic pulmonary fibrosis (IPF). However, PFTs require active participation, which can be challenging for patients with severe respiratory failure, such as during moments of acute exacerbation (AE) of IPF. Recent advances have enabled the re-construction of 3-dimensional computed-tomography (3D-CT) images. This study established a standardisation method and quantitative analysis of lung volume (LV) based on anthropometry using 3D-CT images. METHODS: This is a retrospective multi-center cohort study. The standardised 3D-CT LV in patients with IPF at diagnosis (n = 140) and during AE (cohort1; n = 61 and cohort2; n = 50) and those of controls (n = 53) were assessed. RESULTS: The standardised 3D-CT LVs at IPF diagnosis were less than those of control patients, especially in the lower lung lobes. The standardised 3D-CT LVs were correlated with forced vital capacity (FVC) and validated using the modified Gender-Age-Physiology (GAP) index. The standardised 3D-CT LVs at IPF diagnosis were independently associated with prognosis. During AE, PFTs were difficult to perform, 3D-CT analyses revealed reduced lung capacity in both the upper and lower lobes compared to those obtained at diagnosis. Lower standardised 3D-CT LVs during AE were independently associated with worse outcomes in the two independent cohorts. In particular, volume loss in the upper lobe at AE had prognostic values. CONCLUSIONS: A novel image quantification method for assessing pulmonary physiology using standardised 3D-CT-derived LVs was developed. This method successfully predicts mortality in patients with IPF and AE of IPF, and may be a useful alternative when PFTs cannot be performed. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12931-022-02062-1.
format Online
Article
Text
id pubmed-9161591
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-91615912022-06-03 Standardised 3D-CT lung volumes for patients with idiopathic pulmonary fibrosis Tanaka, Yuko Suzuki, Yuzo Hasegawa, Hirotsugu Yokomura, Koshi Fukada, Atsuki Inoue, Yusuke Hozumi, Hironao Karayama, Masato Furuhashi, Kazuki Enomoto, Noriyuki Fujisawa, Tomoyuki Nakamura, Yutaro Inui, Naoki Suda, Takafumi Respir Res Research BACKGROUND: The assessment of lung physiology via pulmonary function tests (PFTs) is essential for patients with idiopathic pulmonary fibrosis (IPF). However, PFTs require active participation, which can be challenging for patients with severe respiratory failure, such as during moments of acute exacerbation (AE) of IPF. Recent advances have enabled the re-construction of 3-dimensional computed-tomography (3D-CT) images. This study established a standardisation method and quantitative analysis of lung volume (LV) based on anthropometry using 3D-CT images. METHODS: This is a retrospective multi-center cohort study. The standardised 3D-CT LV in patients with IPF at diagnosis (n = 140) and during AE (cohort1; n = 61 and cohort2; n = 50) and those of controls (n = 53) were assessed. RESULTS: The standardised 3D-CT LVs at IPF diagnosis were less than those of control patients, especially in the lower lung lobes. The standardised 3D-CT LVs were correlated with forced vital capacity (FVC) and validated using the modified Gender-Age-Physiology (GAP) index. The standardised 3D-CT LVs at IPF diagnosis were independently associated with prognosis. During AE, PFTs were difficult to perform, 3D-CT analyses revealed reduced lung capacity in both the upper and lower lobes compared to those obtained at diagnosis. Lower standardised 3D-CT LVs during AE were independently associated with worse outcomes in the two independent cohorts. In particular, volume loss in the upper lobe at AE had prognostic values. CONCLUSIONS: A novel image quantification method for assessing pulmonary physiology using standardised 3D-CT-derived LVs was developed. This method successfully predicts mortality in patients with IPF and AE of IPF, and may be a useful alternative when PFTs cannot be performed. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12931-022-02062-1. BioMed Central 2022-06-01 2022 /pmc/articles/PMC9161591/ /pubmed/35650599 http://dx.doi.org/10.1186/s12931-022-02062-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Tanaka, Yuko
Suzuki, Yuzo
Hasegawa, Hirotsugu
Yokomura, Koshi
Fukada, Atsuki
Inoue, Yusuke
Hozumi, Hironao
Karayama, Masato
Furuhashi, Kazuki
Enomoto, Noriyuki
Fujisawa, Tomoyuki
Nakamura, Yutaro
Inui, Naoki
Suda, Takafumi
Standardised 3D-CT lung volumes for patients with idiopathic pulmonary fibrosis
title Standardised 3D-CT lung volumes for patients with idiopathic pulmonary fibrosis
title_full Standardised 3D-CT lung volumes for patients with idiopathic pulmonary fibrosis
title_fullStr Standardised 3D-CT lung volumes for patients with idiopathic pulmonary fibrosis
title_full_unstemmed Standardised 3D-CT lung volumes for patients with idiopathic pulmonary fibrosis
title_short Standardised 3D-CT lung volumes for patients with idiopathic pulmonary fibrosis
title_sort standardised 3d-ct lung volumes for patients with idiopathic pulmonary fibrosis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9161591/
https://www.ncbi.nlm.nih.gov/pubmed/35650599
http://dx.doi.org/10.1186/s12931-022-02062-1
work_keys_str_mv AT tanakayuko standardised3dctlungvolumesforpatientswithidiopathicpulmonaryfibrosis
AT suzukiyuzo standardised3dctlungvolumesforpatientswithidiopathicpulmonaryfibrosis
AT hasegawahirotsugu standardised3dctlungvolumesforpatientswithidiopathicpulmonaryfibrosis
AT yokomurakoshi standardised3dctlungvolumesforpatientswithidiopathicpulmonaryfibrosis
AT fukadaatsuki standardised3dctlungvolumesforpatientswithidiopathicpulmonaryfibrosis
AT inoueyusuke standardised3dctlungvolumesforpatientswithidiopathicpulmonaryfibrosis
AT hozumihironao standardised3dctlungvolumesforpatientswithidiopathicpulmonaryfibrosis
AT karayamamasato standardised3dctlungvolumesforpatientswithidiopathicpulmonaryfibrosis
AT furuhashikazuki standardised3dctlungvolumesforpatientswithidiopathicpulmonaryfibrosis
AT enomotonoriyuki standardised3dctlungvolumesforpatientswithidiopathicpulmonaryfibrosis
AT fujisawatomoyuki standardised3dctlungvolumesforpatientswithidiopathicpulmonaryfibrosis
AT nakamurayutaro standardised3dctlungvolumesforpatientswithidiopathicpulmonaryfibrosis
AT inuinaoki standardised3dctlungvolumesforpatientswithidiopathicpulmonaryfibrosis
AT sudatakafumi standardised3dctlungvolumesforpatientswithidiopathicpulmonaryfibrosis